Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1F28

CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII BOUND TO DUMP AND BW1843U89

1F28 の概要
エントリーDOI10.2210/pdb1f28/pdb
関連するPDBエントリー1CI7
分子名称THYMIDYLATE SYNTHASE, 2'-DEOXYURIDINE 5'-MONOPHOSPHATE, S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID, ... (4 entities in total)
機能のキーワードbeta-sheet, protein-inhibitor complex, transferase
由来する生物種Pneumocystis carinii
タンパク質・核酸の鎖数4
化学式量合計140847.86
構造登録者
Anderson, A.C.,O'Neil, R.H.,Surti, T.S.,Stroud, R.M. (登録日: 2000-05-23, 公開日: 2001-06-06, 最終更新日: 2024-11-13)
主引用文献Anderson, A.C.,O'Neil, R.H.,Surti, T.S.,Stroud, R.M.
Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking.
Chem.Biol., 8:445-457, 2001
Cited by
PubMed Abstract: Using fixed receptor sites derived from high-resolution crystal structures in structure-based drug design does not properly account for ligand-induced enzyme conformational change and imparts a bias into the discovery and design of novel ligands. We sought to facilitate the design of improved drug leads by defining residues most likely to change conformation, and then defining a minimal manifold of possible conformations of a target site for drug design based on a small number of identified flexible residues.
PubMed: 11358692
DOI: 10.1016/S1074-5521(01)00023-0
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 1f28
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon